Slovenian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
colchicine/mrzlica
Povezava se shrani v odložišče
Stran 1 iz 1274 rezultatov
Novel therapeutics for the treatment of familial Mediterranean fever: from colchicine to biologics.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
Familial Mediterranean fever (FMF), an inherited autosomal recessive disorder, is characterized by sporadic, paroxysmal attacks of fever and serosal inflammation, lasting 1-3 days. Patients may develop renal amyloidosis, arthritis, serositis, and skin and oral lesions. Diagnosis is based on clinical
Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
BACKGROUND
This open-label pilot study aimed to investigate the efficacy of canakinumab in colchicine-resistant familial Mediterranean fever (FMF) patients.
METHODS
Patients with one or more attacks in a month in the preceding 3 months despite colchicine were eligible to enter a 30-day run-in
Efficacy of colchicine therapy in amyloid nephropathy of familial Mediterranean fever.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
The aim of this study was to investigate the effect of colchicine therapy on the outcome of amyloid nephropathy of familial Mediterranean fever (FMF) in childhood. The diagnosis of amyloidosis type AA was confirmed by renal biopsy in 38 patients. During a mean follow-up period of 30.5 months (range
Effect of colchicine on immunoregulatory abnormalities in familial Mediterranean fever.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
The effect of colchicine on immunoregulatory T lymphocytes in children with familial Mediterranean fever (FMF) was studied. Concanavalin A (Con A)-induced suppressor cell function was significantly (P less than 0.0001) decreased in five untreated FMF patients (15 +/- 3%, mean +/- s.e.) as compared
Correction of a suppressor cell deficiency in familial Mediterranean fever by colchicine.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
We have previously reported a suppressor cell deficiency in four patients with familial Mediterranean fever (FMF). Since colchicine prevents FMF attacks, we tested the effect of colchicine (1 mg twice daily) on the suppressor cell function in three of these FMF patients. Proliferation of
Colchicine enhances intestinal permeability in patients with familial Mediterranean fever.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
OBJECTIVE
Colchicine therapy is complicated by frequent gastrointestinal adverse effects.
METHODS
We compared intestinal permeability in 21 patients with familial Mediterranean fever on long-standing colchicine therapy (mean 5.8 years) and significant gastrointestinal complaints and 12 untreated
Gastrointestinal effects of long-term colchicine therapy in patients with recurrent polyserositis (familial mediterranean fever).
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
Twelve patients with recurrent polyserositis (RP, familial Mediterranean fever) on colchicine prophylaxis (1.0-2.0 mg daily) for three years or more were evaluated for the presence of gastrointestinal effects possibly attributable to the drug. Two patients had bulky stools, two others had transient
Intravenous colchicine for treatment of patients with familial Mediterranean fever unresponsive to oral colchicine.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
OBJECTIVE
To evaluate the efficacy and safety of weekly intravenous (IV) colchicine, in addition to oral colchicine therapy, in a subset of patients with familial Mediterranean fever (FMF) unresponsive to oral colchicine prophylaxis.
METHODS
Thirteen patients with frequent FMF attacks, despite oral
Efficacy and safety of long-term treatment with intravenous colchicine for familial Mediterranean fever (FMF) refractory to oral colchicine.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
Colchicine is the mainstay of treatment for familial Mediterranean fever (FMF). Intravenous (IV) colchicine, administered over several months, has been shown to be effective for FMF patients unresponsive to oral colchicine. The objective of this study was to evaluate the efficacy and safety of
Colchicine concentration in leukocytes of patients with familial Mediterranean fever.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
Free and total plasma, granulocyte and mononuclear cell colchicine concentrations were measured by radioimmunoassay in 30 patients with familial Mediterranean fever treated with colchicine 0.5 to 2 mg day-1. Colchicine concentrations showed a large intersubject variability in plasma (0.13-1.75 ng
Long-term colchicine therapy of familial Mediterranean fever.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
Familial Mediterranean fever is a disorder characterized by recurrent fever and polyserositis. Continuous prophylactic colchicine therapy has been effective in suppressing attacks in affected adults. From 30 children with FMF, 14 were selected for colchicine therapy. Eight children continued
Can colchicine response be predicted in familial Mediterranean fever patients?
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
OBJECTIVE
The aims of this study were to explore whether the demographic and clinical features of paediatric familial Mediterranean fever (FMF) patients with different colchicine response vary or not and to determine whether colchicine response can be predicted in FMF patients.
METHODS
Files of
Colchicine in breast milk of patients with familial Mediterranean fever.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
OBJECTIVE
To clarify whether colchicine is excreted in breast milk, and to compare its concentrations in the serum and breast milk of lactating women who have familial Mediterranean fever (FMF).
METHODS
Using a specific radioimmunoassay, we determined colchicine concentrations in the serum and
Colchicine in tear fluid of treated patients with familial Mediterranean fever.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
OBJECTIVE
The study aimed to determine whether detectable concentrations of colchicine are present in the tear fluid of treated patients with familial Mediterranean fever (FMF) and thus demonstrate a possible route by which colchicine reaches the corneal surface.
METHODS
Tear fluid samples (50-100
Colchicine kinetics in patients with familial Mediterranean fever.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
Serum colchicine levels were determined by radioimmunoassay after a 1-mg bolus injected intravenously in 4 patients with familial Mediterranean fever and in 6 normal subjects. Mean elimination half-life (t1/2) (+/- SEM) was 157 +/- 20 min in the patients and 65 +/- 15 min in the normal subjects (p
Najbolj popolna baza zdravilnih zelišč, podprta z znanostjo
- Deluje v 55 jezikih
- Zeliščna zdravila, podprta z znanostjo
- Prepoznavanje zelišč po sliki
- Interaktivni GPS zemljevid - označite zelišča na lokaciji (kmalu)
- Preberite znanstvene publikacije, povezane z vašim iskanjem
- Iščite zdravilna zelišča po njihovih učinkih
- Organizirajte svoje interese in bodite na tekočem z raziskavami novic, kliničnimi preskušanji in patenti
Vnesite simptom ali bolezen in preberite o zeliščih, ki bi lahko pomagala, vnesite zelišče in si oglejte bolezni in simptome, proti katerim se uporablja.
* Vse informacije temeljijo na objavljenih znanstvenih raziskavah
